Supernormal Oxygen Delivery for Patients With Severe Burns

• Status: Not yet recruiting
• Trial end date: 2023-06-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a randomized double-blinded study to investigate in which the groups are designated as the control group and the goal-directed fluid therapy group to further evaluate significant differences in rate of complications during burn surgery.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Guangzhou Red Cross Hospital
• Treatments: Dobutamine

Criteria

Inclusion Criteria:

• Severe burn patients

Exclusion Criteria:

• Patients or families refuse to sign consent